You are here

  • Home
  • Archive
  • Volume 71, Issue 2
  • Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial

Article info

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial

Authors

  1. Correspondence to Jeffrey R Curtis, University of Alabama at Birmingham, FOT 805D 510 20th Street South, Birmingham, AL 35294, USA; jcurtis{at}uab.edu
View Full Text

Citation

Curtis JR, Yang S, Chen L, et al
Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial
Annals of the Rheumatic Diseases 2012;71:206-212.

Publication history

  • Accepted September 17, 2011
  • First published October 13, 2011.
Online issue publication 
March 19, 2024

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions